The boring parts, done properly.
MyDosage is a consumer product. Underneath it sits a compound registry with sources and dates, a supply taxonomy that keeps medicines, compounding pharmacies and research-use-only suppliers apart, and a structured record of what people actually take and what happens next. If any of that is useful to your team, this page is for you.
Medication management
Patients on GLP-1s and other injectables get a dose schedule, reminders, titration context and a single measure to report against. What they log stays theirs; what you see is what they choose to share.
Evidence registry
Every compound entry carries its sources, an evidence tier and a last-reviewed date. Where the human evidence is thin, the page says so instead of implying more.
Real-world data, structured
Usage periods, doses, stop reasons and one headline measure per goal — collected consistently, reported only in aggregate, and never below five separate journeys.
Supply layer clarity
Every listed entity carries exactly one layer: approved medicine, compounding pharmacy, or research-use-only supplier. Nothing is blended.
Data and trials readiness
Cohorts can be described by compound, goal, dose pattern and duration. Exports are aggregate and de-identified. We hold no certifications and claim none; if a study needs a formal agreement, we will negotiate one rather than pretend it already exists.
Talk to us
Write to clinical@mydosage.com with what you are trying to answer. A person replies — no form sequence, no deck.